SRPT: Sarepta Therapeutics Inc
SRPT exchange rate has changed by -5.46% for today. During the day, the instrument was traded at a low of 15.66 and at a high of 16.69.
Follow Sarepta Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
SRPT News
- Why Is Sarepta Therapeutics (SRPT) Down 19.9% Since Last Earnings Report?
- KROS Turns to Next Wave of TGF-Beta Muscle Therapies
- KROS Turns to Next Wave of TGF-Beta Muscle Therapies
- Should You Buy KROS After Q1 Miss and Takeda Deal Reset?
- Should You Buy KROS After Q1 Miss and Takeda Deal Reset?
- KROS Stock Guide to Rinvatercept in DMD and ALS for 2026
- KROS Stock Guide to Rinvatercept in DMD and ALS for 2026
- Stock Market Soars On Tumbling Oil Prices, Strong Earnings: Weekly Review
- Sarepta's Q1 Earnings & Sales Beat Estimates, '26 Outlook Maintained
- Sarepta Dives; Can 2026 Be The Reset Year For Its Controversial Gene Therapy?
- Sarepta Therapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:SRPT) 2026-05-06
- Sarepta Therapeutics (SRPT) Reports Q1 Earnings: What Key Metrics Have to Say
- Sarepta Therapeutics (SRPT) Q1 Earnings and Revenues Top Estimates
- Are These 5 Biotech Stocks Set to Beat Q1 Earnings Estimates?
- Sarepta Therapeutics (SRPT) Reports Next Week: Wall Street Expects Earnings Growth
- Ocugen Stock Outlook: Valuation, Cash Runway and Dilution Risk
- Ocugen Stock Outlook: Valuation, Cash Runway and Dilution Risk
- OCGN's Gene-Agnostic Strategy Could Reset Retinal Therapy
- OCGN's Gene-Agnostic Strategy Could Reset Retinal Therapy
- KROS 2026 Watchlist: 3 Catalysts That Could Reset Sentiment
- KROS Stock: Does the Takeda Deal Lower Dilution Risk in 2026?
- KROS Rinvatercept: What to Know Before DMD Phase II Starts
- Why Is Sarepta Therapeutics (SRPT) Up 24.2% Since Last Earnings Report?
- SRPT Stock Surges on Promising Early Results From siRNA Programs
Frequently Asked Questions
What is SRPT stock price today?
Sarepta Therapeutics Inc stock is priced at 15.75 today. It trades within 15.66 - 16.69, yesterday's close was 16.66, and trading volume reached 5370. The live price chart of SRPT shows these updates.
Does Sarepta Therapeutics Inc stock pay dividends?
Sarepta Therapeutics Inc is currently valued at 15.75. Dividend policy depends on the company, while investors also watch -8.16% and USD. View the chart live to track SRPT movements.
How to buy SRPT stock?
You can buy Sarepta Therapeutics Inc shares at the current price of 15.75. Orders are usually placed near 15.75 or 16.05, while 5370 and -5.06% show market activity. Follow SRPT updates on the live chart today.
How to invest into SRPT stock?
Investing in Sarepta Therapeutics Inc involves considering the yearly range 10.41 - 25.32 and current price 15.75. Many compare -10.00% and -28.15% before placing orders at 15.75 or 16.05. Explore the SRPT price chart live with daily changes.
What are Sarepta Therapeutics Inc stock highest prices?
The highest price of Sarepta Therapeutics Inc in the past year was 25.32. Within 10.41 - 25.32, the stock fluctuated notably, and comparing with 16.66 helps spot resistance levels. Track Sarepta Therapeutics Inc performance using the live chart.
What are Sarepta Therapeutics Inc stock lowest prices?
The lowest price of Sarepta Therapeutics Inc (SRPT) over the year was 10.41. Comparing it with the current 15.75 and 10.41 - 25.32 shows potential long-term entry points. Watch SRPT moves on the chart live for more details.
When did SRPT stock split?
Sarepta Therapeutics Inc has gone through stock splits historically. These changes are visible in , 16.66, and -8.16% after corporate actions.
- Previous Close
- 16.66
- Open
- 16.59
- Bid
- 15.75
- Ask
- 16.05
- Low
- 15.66
- High
- 16.69
- Volume
- 5.370 K
- Daily Change
- -5.46%
- Month Change
- -10.00%
- 6 Months Change
- -28.15%
- Year Change
- -8.16%
- Act
- Fcst
- Prev